AHC.ASX: Appendix 4E & FY26 Financial Statements

Appendix 4E & FY26 Financial Statements

Stock	Austco Healthcare Ltd (AHC.ASX)
Release Time	27 Aug 2026, 5:43 p.m.
Price Sensitive	Yes

This feature provides summaries of price-sensitive announcements for companies followed by users on InvestorPA. The summaries are generated by large language models so please interpret with care.

Austco Healthcare Ltd FY26 Financial Results

Key Points

Record revenue of $94.2 million, up 16% YoY
EBITDA of $14.9 million, up 14% YoY
Net Profit After Tax of $9.0 million, up 52% YoY
Unfilled Contracted Revenue at $51.2 million, up 13%
Cash on hand at $16.3 million, up from $14.5 million

Full Summary

Austco Healthcare Ltd announced its FY26 financial results, reporting a record revenue of $94.2 million, up 16% from FY25. The company's EBITDA increased by 14% to $14.9 million, and Net Profit After Tax rose significantly by 52% to $9.0 million. The company's Unfilled Contracted Revenue (UCR) stood at $51.2 million, reflecting a 13% increase. The company also maintained a strong cash position with $16.3 million on hand at the end of the financial year. The results demonstrate the company's continued growth and profitability, driven by organic growth and successful integration of acquisitions.

Guidance

FY27 EBITDA expected to be over $15 million

Outlook

Austco Healthcare Ltd anticipates continued growth in FY27, driven by organic expansion and further integration of acquired businesses.